Participants will receive continuous subcutaneous infusion (CSCI) (under the skin) of ABBV-951 for 96 weeks during the Primary Treatment Period and during the optional Extended Treatment Period
These weight loss medications are an excellent option for individuals seeking a different approach to weight loss, as they are highly effective when used in conjunction with a balanced diet and regular exercise
Dr Angela Kwong, a Sydney-based GP and obesity expert, explains: "Because the medication works at multiple levels, the gut, the brain, the hormonal system, the whole experience of eating can shift
PubMed Central, Dong, Shichao, and Chuan Sun
Journal of clinical & translational endocrinology, 35, 100333